Literature DB >> 1937690

Endothelium-derived vasoactive factors: I. Endothelium-dependent relaxation.

J T Shepherd1, Z S Katusić.   

Abstract

Evidence continues to accumulate on the importance of paracrine substances formed in the vascular endothelium in the regulation of the vascular system. Those that relax the underlying smooth muscle include nitric oxide, prostacyclin, and an unidentified hyperpolarizing factor; those causing contraction include angiotensin II, endothelin, oxygen-derived free radicals, prostacyclin H2, and thromboxane A2. Determination of the mechanisms governing the formation and release of these substances in different blood vessels of the same species and in different species as well as the maintenance of the balance between them is important for understanding their role in normal circumstances and in diseases of the blood vessels. In this article, we will summarize the current understanding of the role of endothelium-derived relaxing factors and discuss the possibility that endothelial dysfunction may play a primary as well as a secondary role in the pathogenesis of primary hypertension. As a consequence of this dysfunction, substances formed in the endothelial cells at the sites of the arterial baroreceptors could lead to their resetting, resulting in less inhibition of the vasomotor centers, enhanced neurohumoral activity, and a consequential increase in systemic vascular resistance. This increase could be enhanced by a predominant action of endothelium-derived contracting factors in the resistance vessels. Proliferation of the vascular smooth muscle would follow, because of the mitogenic action of some of these factors and other growth promotors. By these mechanisms, the endothelium may participate in the polygenic dysfunction characteristic of primary hypertension, not only in initiating the increase in arterial blood pressure, but also in sustaining it.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937690     DOI: 10.1161/01.hyp.18.5_suppl.iii76

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

Review 1.  Vascular effects of prostacyclin: does activation of PPARδ play a role?

Authors:  Zvonimir S Katusic; Anantha V Santhanam; Tongrong He
Journal:  Trends Pharmacol Sci       Date:  2012-06-23       Impact factor: 14.819

2.  A case of variant angina in a patient under chronic treatment with sorafenib.

Authors:  Italo Porto; Andrea Leo; Luca Miele; Maurizio Pompili; Raffaele Landolfi; Filippo Crea
Journal:  Nat Rev Clin Oncol       Date:  2010-05-18       Impact factor: 66.675

3.  Components of flow-induced dilation in rat perfused coronary artery.

Authors:  P Véquaud; J L Freslon
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

Review 4.  Prinzmetal's variant angina.

Authors:  S Mayer; L D Hillis
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

5.  Effects of cyclooxygenase inhibition on vascular responses evoked in fingers of men and women by iontophoresis of 1- and 2-adrenoceptor agonists.

Authors:  Amar Srinivasa; Janice M Marshall
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

6.  Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.

Authors:  William A Chutkow; Jielin Pu; Matthew T Wheeler; Tomoyuki Wada; Jonathan C Makielski; Charles F Burant; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect.

Authors:  James L Park; Steven E Whitesall; Louis G D'Alecy; Liming Shu; James A Shayman
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-06-18       Impact factor: 2.557

8.  Influence of nitric oxide synthase inhibition on pulmonary O2 uptake kinetics during supra-maximal exercise in humans.

Authors:  Daryl P Wilkerson; Iain T Campbell; Andrew M Jones
Journal:  J Physiol       Date:  2004-09-09       Impact factor: 5.182

9.  N omega-nitro-L-arginine, an inhibitor of nitric oxide synthesis, decreases noradrenaline outflow in rat isolated perfused mesenteric vasculature.

Authors:  R Yamamoto; A Wada; Y Asada; H Niina; A Sumiyoshi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

10.  Recent insights into the mechanisms of vasospastic angina.

Authors:  Sang-Yong Yoo; Jang-Young Kim
Journal:  Korean Circ J       Date:  2009-12-30       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.